Is estradiol a genotoxic mutagenic carcinogen?
- PMID: 10696569
- DOI: 10.1210/edrv.21.1.0386
Is estradiol a genotoxic mutagenic carcinogen?
Abstract
The natural hormone 17 beta-estradiol (E2) induces tumors in various organs of rats, mice, and hamsters. In humans, slightly elevated circulating estrogen levels caused either by increased endogenous hormone production or by therapeutic doses of estrogen medications increase breast or uterine cancer risk. Several epigenetic mechanisms of tumor induction by this hormone have been proposed based on its lack of mutagenic activity in bacterial and mammalian cell test systems. More recent evidence supports a dual role of estrogen in carcinogenesis as a hormone stimulating cell proliferation and as a procarcinogen inducing genetic damage. Tumors may be initiated by metabolic conversion of E2 to 4-hydroxyestradiol catalyzed by a specific 4-hydroxylase (CYP1B1) and by further activation of this catechol to reactive semiquinone/quinone intermediates. Several types of direct and indirect free radical-mediated DNA damage are induced by E2, 4-hydroxyestradiol, or its corresponding quinone in cell-free systems, in cells in culture, and/or in vivo. E2 also induces various chromosomal and genetic lesions including aneuploidy, chromosomal aberrations, gene amplification, and microsatellite instability in cells in culture and/or in vivo and gene mutations in several cell test systems. These data suggest that E2 is a weak carcinogen and weak mutagen capable of inducing genetic lesions with low frequency. Tumors may develop by hormone receptor-mediated proliferation of such damaged cells.
Similar articles
-
Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney.Toxicol Appl Pharmacol. 1994 Mar;125(1):149-58. doi: 10.1006/taap.1994.1059. Toxicol Appl Pharmacol. 1994. PMID: 8128490
-
Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens.Endocrinology. 1992 Aug;131(2):655-61. doi: 10.1210/endo.131.2.1386303. Endocrinology. 1992. PMID: 1386303
-
Involvement of caspase-9 but not caspase-8 in the anti-apoptotic effects of estradiol and 4-OH-Estradiol in MCF-7 human breast cancer cells.Endocr Regul. 2011 Jan;45(1):3-8. Endocr Regul. 2011. PMID: 21314204
-
Cytochrome P450 1 family and cancers.J Steroid Biochem Mol Biol. 2015 Mar;147:24-30. doi: 10.1016/j.jsbmb.2014.11.003. Epub 2014 Nov 6. J Steroid Biochem Mol Biol. 2015. PMID: 25448748 Review.
-
Estrogen, DNA damage and mutations.Mutat Res. 1999 Mar 8;424(1-2):107-15. doi: 10.1016/s0027-5107(99)00012-3. Mutat Res. 1999. PMID: 10064854 Review.
Cited by 107 articles
-
Estrogen Signaling Induces Mitochondrial Dysfunction-Associated Autophagy and Senescence in Breast Cancer Cells.Biology (Basel). 2020 Apr 1;9(4):68. doi: 10.3390/biology9040068. Biology (Basel). 2020. PMID: 32244623 Free PMC article.
-
Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.Cancer Lett. 2020 Apr 28;476:152-160. doi: 10.1016/j.canlet.2020.02.017. Epub 2020 Feb 15. Cancer Lett. 2020. PMID: 32067992
-
Phosphorylation of human placental aromatase CYP19A1.Biochem J. 2019 Nov 15;476(21):3313-3331. doi: 10.1042/BCJ20190633. Biochem J. 2019. PMID: 31652308
-
Estrogen receptors genotypes and canine mammary neoplasia.BMC Vet Res. 2019 Sep 10;15(1):325. doi: 10.1186/s12917-019-2062-y. BMC Vet Res. 2019. PMID: 31506083 Free PMC article.
-
Intranuclear Mobility of Estrogen Receptor: Implication for Transcriptional Regulation.Acta Histochem Cytochem. 2018 Aug 29;51(4):129-136. doi: 10.1267/ahc.18023. Epub 2018 Aug 23. Acta Histochem Cytochem. 2018. PMID: 30279614 Free PMC article.
